aprepitant 125 MG Oral Capsule [Emend]

RxCUI: 404466
RxNorm name: aprepitant 125 MG Oral Capsule [Emend]
Display name: aprepitant 125 MG Oral Capsule [Emend]
Full name: aprepitant 125 MG Oral Capsule [Emend]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
EMEND	APREPITANT	Merck Sharp & Dohme LLC	696f9e80-9cae-403b-de9e-078343ce4713	2024-07-05	Warnings, Adverse reactions	Exact identifier rxcui: 404466

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
696f9e80-9cae-403b-de9e-078343ce4713	Emend 125 MG Oral Capsule [PSN] · aprepitant 125 MG Oral Capsule [Emend] [SBD] · Emend 125 MG Oral Capsule [SY]	3	42	These highlights do not include all the information needed to use EMEND CAPSULES and EMEND FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EMEND CAPSULES and EMEND FOR ORAL SUSPENSION. EMEND (aprepitant) capsules, for oral use EMEND (aprepitant) for oral suspension Initial U.S. Approval: 2003	20240705
db16d6b9-3b89-431d-97f9-9b4a8300e913	Emend 125 MG Oral Capsule [PSN] · aprepitant 125 MG Oral Capsule [Emend] [SBD] · Emend 125 MG Oral Capsule [SY]	3	3	These highlights do not include all the information needed to use EMEND safely and effectively. See full prescribing information for EMEND. EMEND (aprepitant) Capsules Initial U.S. Approval: 2003	20100319